BRPI0911970A2 - quinazolinas substituídas e seus usos para doenças mieloproliferativas e doenças trombóticas generalizadas. - Google Patents

quinazolinas substituídas e seus usos para doenças mieloproliferativas e doenças trombóticas generalizadas.

Info

Publication number
BRPI0911970A2
BRPI0911970A2 BRPI0911970A BRPI0911970A BRPI0911970A2 BR PI0911970 A2 BRPI0911970 A2 BR PI0911970A2 BR PI0911970 A BRPI0911970 A BR PI0911970A BR PI0911970 A BRPI0911970 A BR PI0911970A BR PI0911970 A2 BRPI0911970 A2 BR PI0911970A2
Authority
BR
Brazil
Prior art keywords
disorders
substituted quinazolines
myeloproliferative
generalized
generalized thrombotic
Prior art date
Application number
BRPI0911970A
Other languages
English (en)
Inventor
Bernard Golding
Richard Franklin
Original Assignee
Shire Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire Llc filed Critical Shire Llc
Publication of BRPI0911970A2 publication Critical patent/BRPI0911970A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BRPI0911970A 2008-05-16 2009-05-13 quinazolinas substituídas e seus usos para doenças mieloproliferativas e doenças trombóticas generalizadas. BRPI0911970A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0808952.6A GB0808952D0 (en) 2008-05-16 2008-05-16 Substituted quinazolines
PCT/GB2009/050510 WO2009138790A1 (en) 2008-05-16 2009-05-13 Substituted quinazolines and their uses for myeoloprolific and thrombotic diseases

Publications (1)

Publication Number Publication Date
BRPI0911970A2 true BRPI0911970A2 (pt) 2015-10-13

Family

ID=39596031

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0911970A BRPI0911970A2 (pt) 2008-05-16 2009-05-13 quinazolinas substituídas e seus usos para doenças mieloproliferativas e doenças trombóticas generalizadas.

Country Status (10)

Country Link
US (1) US20110086851A1 (pt)
EP (1) EP2297156A1 (pt)
JP (1) JP2011520860A (pt)
KR (3) KR20110021901A (pt)
CN (1) CN102076697A (pt)
AU (1) AU2009247791A1 (pt)
BR (1) BRPI0911970A2 (pt)
CA (1) CA2724020A1 (pt)
GB (1) GB0808952D0 (pt)
WO (1) WO2009138790A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7910597B2 (en) * 2006-11-28 2011-03-22 Shire Llc Substituted quinazolines
US8304420B2 (en) * 2006-11-28 2012-11-06 Shire Llc Substituted quinazolines for reducing platelet count
JP2023533016A (ja) 2020-07-11 2023-08-01 ファイザー・インク 抗ウイルス性ヘテロアリールケトン誘導体
US11351149B2 (en) 2020-09-03 2022-06-07 Pfizer Inc. Nitrile-containing antiviral compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7807507A (nl) * 1977-07-25 1979-01-29 Hoffmann La Roche Tricyclische verbindingen.
ZA803535B (en) * 1979-06-20 1981-06-24 Hoffmann La Roche Novel quinazoline derivatives and pharmaceutical preparations
US4670434A (en) * 1985-11-14 1987-06-02 Syntex (U.S.A.) Inc. (2-oxo-3-methylene-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolinyl)oxyalkylamides useful as cyclic AMP phosphodiesterase inhibitors
US4943573A (en) * 1989-11-01 1990-07-24 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility
DK0571253T3 (da) * 1992-05-19 1999-07-19 Adir Benzimidazolderivater med antidiabetisk og antiblodpladekoagulerende virkning
US20060030574A1 (en) * 2004-08-04 2006-02-09 Shire Holdings Ag Quinazoline derivatives useful for the treatment of peripheral arterial disease and as phosphodiesterase inhibitors
US7700608B2 (en) * 2004-08-04 2010-04-20 Shire Holdings Ag Quinazoline derivatives and their use in the treatment of thrombocythemia

Also Published As

Publication number Publication date
US20110086851A1 (en) 2011-04-14
KR20110021901A (ko) 2011-03-04
KR20110021883A (ko) 2011-03-04
CN102076697A (zh) 2011-05-25
GB0808952D0 (en) 2008-06-25
KR20110018354A (ko) 2011-02-23
JP2011520860A (ja) 2011-07-21
EP2297156A1 (en) 2011-03-23
AU2009247791A1 (en) 2009-11-19
CA2724020A1 (en) 2009-11-19
WO2009138790A1 (en) 2009-11-19

Similar Documents

Publication Publication Date Title
BRPI0718182A2 (pt) Oligorribonucleotídeos e seus usos.
BRPI0910746A2 (pt) reticuladores e seus usos
BRPI1016150A2 (pt) compostos heterocíclicos e seus usos.
BRPI1011801A2 (pt) membranas biométricas e seus usos.
BRPI0921862A2 (pt) inibidores de raf e seus usos
BRPI0909185A2 (pt) Derivado de vitamina e e seus usos
BR112013006272A2 (pt) compostos de piridina e seus usos
BRPI0911669A8 (pt) sistemas e métodos para o aperfeiçoamento da eficiência da disposição de orifício de catéter
BRPI0812005A2 (pt) anticorpos humanizados para o globulômeros de ab(20-42) e seus usos.
BRPI0912284A2 (pt) Polímeros antimicrobianos e seus usos
BR112012002114A2 (pt) cevadas e seu usos.
BRPI0817881A2 (pt) Compostos orgânicos e seus usos
BRPI0919368A2 (pt) dispositivos e métodos para planejar localizações de poços com critérios dinâmicos de produção
BRPI0813244A2 (pt) Compostos e seus usos 708
BRPI0808098A2 (pt) 4-aril-1,4-di-hidro-1,6-naftiridinamidas substituídas e seu uso
BRPI1010540A2 (pt) "anticorpos especéficos para dkk-1 e seus usos"
PT2473527T (pt) Formulações estáveis de polipéptidos e seus usos
BRPI0906498A2 (pt) Anticorpo ron e seus usos
BRPI0812367A2 (pt) Dispositivos interoclusais e respectivos métodos de fabrico
PT2496533T (pt) Ligantes para materiais de construção
BRPI0816075A2 (pt) 2-(fenil substituído)-6-amino-5-alcóxi, tioalcóxi e aminoalquil-4-pirimidinacarboxilatos e seus usos como herbicidas
BR112013005523A2 (pt) composto como inibidores de quinase c-met e seus usos
BR112012005403A2 (pt) cadeira para criança
BRPI0717638A2 (pt) Anticorpors e imunoconjugados e usos para os mesmos
BRPI1016067A2 (pt) ésteres e seus usos.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.